当前位置:首页 - 行情中心 - 新华医疗(600587) - 财务分析 - 现金流量表

新华医疗

(600587)

  

流通市值:99.18亿  总市值:103.98亿
流通股本:4.45亿   总股本:4.67亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金10,562,308,202.797,428,162,090.935,081,529,554.212,560,574,772.73
收到的税费返还29,834,063.74238,154.63195,325.74394,496.68
收到其他与经营活动有关的现金253,685,954.47238,640,567.61125,562,137.81116,705,281.29
经营活动现金流入的平衡项目0000
经营活动现金流入小计10,845,828,2217,667,040,813.175,207,287,017.762,677,674,550.7
购买商品、接受劳务支付的现金6,932,999,917.175,216,690,482.633,424,857,085.961,833,717,572.07
支付给职工以及为职工支付的现金1,670,820,548.891,229,225,749.87837,512,702.17451,185,512.38
支付的各项税费449,401,508.57383,548,744.54260,569,422.12135,705,263.76
支付其他与经营活动有关的现金762,491,767.2549,633,414.18382,208,422.91240,931,582.46
经营活动现金流出的平衡项目0000
经营活动现金流出小计9,815,713,741.837,379,098,391.224,905,147,633.162,661,539,930.67
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,030,114,479.17287,942,421.95302,139,384.616,134,620.03
二、投资活动产生的现金流量:
收回投资收到的现金54,334,354.91123,137,059.0257,248,387.131,778,853.05
取得投资收益收到的现金16,713,443.31349,273.51193,503.93127,043.16
处置固定资产、无形资产和其他长期资产收回的现金净额2,590,214.87149,536.59133,087.91102,137.91
处置子公司及其他营业单位收到的现金净额1,239,948.66,530,848.6--
投资活动现金流入的平衡项目0000
投资活动现金流入小计74,877,961.69130,166,717.7257,574,978.9432,008,034.12
购建固定资产、无形资产和其他长期资产支付的现金535,770,209.66433,370,764.31265,605,042.76107,157,526.4
投资支付的现金59,006,796.12133,344,652.8360,744,652.8364,778,262.53
投资活动现金流出的平衡项目0000
投资活动现金流出小计594,777,005.78566,715,417.14326,349,695.59171,935,788.93
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-519,899,044.09-436,548,699.42-268,774,716.65-139,927,754.81
三、筹资活动产生的现金流量:
吸收投资收到的现金1,278,858,913.791,289,086,491.241,276,964,291.241,276,964,291.24
其中:子公司吸收少数股东投资收到的现金2,620,000---
取得借款收到的现金966,970,000862,440,000570,040,000341,150,000
收到其他与筹资活动有关的现金200,415,680.956,000,0006,000,000-
筹资活动现金流入平衡项目0000
筹资活动现金流入小计2,446,244,594.742,157,526,491.241,853,004,291.241,618,114,291.24
偿还债务支付的现金1,090,970,0001,055,276,707.55770,396,774.12433,191,995.54
分配股利、利润或偿付利息支付的现金110,423,648.29110,349,752.2597,773,433.2911,888,952.53
其中:子公司支付给少数股东的股利、利润6,622,038.264,390,000--
支付其他与筹资活动有关的现金179,060,308.5751,588,824.4241,673,843.17-
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,380,453,956.861,217,215,284.22909,844,050.58445,080,948.07
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额1,065,790,637.88940,311,207.02943,160,240.661,173,033,343.17
四、汇率变动对现金及现金等价物的影响6,947,499.57729,439.87792,843.81207,776.26
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额1,582,953,572.53792,434,369.42977,317,752.421,049,447,984.65
加:期初现金及现金等价物余额1,457,878,147.191,457,878,147.191,457,878,147.191,457,878,147.19
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,040,831,719.722,250,312,516.612,435,195,899.612,507,326,131.84
补充资料:
净利润676,501,383.22-477,586,988.66-
资产减值准备47,477,564.31-13,092,418.43-
固定资产和投资性房地产折旧166,366,903.9-82,726,609.48-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧166,366,903.9-82,726,609.48-
无形资产摊销20,662,194.81-8,603,098.95-
长期待摊费用摊销45,120,050.76-24,106,168.94-
处置固定资产、无形资产和其他长期资产的损失-3,754,207.14--57,618.31-
固定资产报废损失646,935.99-791,605.69-
公允价值变动损失-12,536,023.66-39,684,757.06-
财务费用40,124,323.79-20,662,326.21-
投资损失-81,117,962.39--30,485,908.95-
递延所得税-12,329,162.38-13,505,910.83-
其中:递延所得税资产减少-25,618,122.42--2,478,296.19-
递延所得税负债增加13,288,960.04-15,984,207.02-
存货的减少-540,026,809.38--137,340,856.38-
经营性应收项目的减少6,817,813.62--191,994,226.32-
经营性应付项目的增加563,583,337.24--55,176,909.94-
其他--17,222,815.06-
现金的期末余额3,040,831,719.72-2,435,195,899.61-
减:现金的期初余额1,457,878,147.19-1,457,878,147.19-
公告日期2024-03-292023-10-252023-08-232023-04-28
审计意见(境内)标准无保留意见
TOP↑